SEC Comment Letter for Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Aug 22, 2019
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Aug. 22, 2019 · CIK: 0000890821 · Accession: 0000000000-19-012757
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233260
Letter
August 19, 2019 Brent Kelton Chief Executive Officer AMERI Holdings, Inc. 5000 Research Court, Suite 750 Suwanee, Georgia, 30024 Re:AMERI Holdings, Inc. Registration Statement on Form S-3 Filed August 14, 2019 File No. 333-233260 Dear Mr. Kelton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Heather Percival at 202-551-3498 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Richard A. Friedman, Esq.
Show Raw Text
August 19, 2019
Brent Kelton
Chief Executive Officer
AMERI Holdings, Inc.
5000 Research Court, Suite 750
Suwanee, Georgia, 30024
Re:AMERI Holdings, Inc.
Registration Statement on Form S-3
Filed August 14, 2019
File No. 333-233260
Dear Mr. Kelton:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Heather Percival at 202-551-3498 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Richard A. Friedman, Esq.